Because its effects on fetal and infant development are unknown, its best to avoid use unless prescribed and monitored by a qualified healthcare provider
That could indirectly contribute to a rise in platelet count
Studies in mice have shown it to be an effective delivery method for systemic effects, such as suppressing age-related cognitive decline
Peptides degrade rapidly and dont produce long-lasting metabolites, making them nearly invisible in standard immunoassay urine tests
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry